Switch to:

GuruFocus Financial Strength Rank measures how strong a company’s financial situation is. It is based on these factors

1. The debt burden that the company has as measured by its Interest coverage (current year).
2. Debt to revenue ratio. The lower, the better
3. Altman Z-score.

A company ranks high with financial strength is likely to withstand any business slowdowns and recessions.

Financial Strength : 7/10

vs
industry
vs
history
Cash to Debt 0.23
PKI's Cash to Debt is ranked higher than
52% of the 309 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 1.30 vs. PKI: 0.23 )
PKI' s 10-Year Cash to Debt Range
Min: 0.09   Max: 2.06
Current: 0.23

0.09
2.06
Equity to Asset 0.52
PKI's Equity to Asset is ranked higher than
64% of the 303 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 0.60 vs. PKI: 0.52 )
PKI' s 10-Year Equity to Asset Range
Min: 0.24   Max: 0.63
Current: 0.52

0.24
0.63
Interest Coverage 4.36
PKI's Interest Coverage is ranked higher than
53% of the 206 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 26.96 vs. PKI: 4.36 )
PKI' s 10-Year Interest Coverage Range
Min: 2.15   Max: 16.75
Current: 4.36

2.15
16.75
F-Score: 7
Z-Score: 3.14
M-Score: -2.48
GuruFocus Profitability Rank ranks how profitable a company is and how likely the company’s business will stay that way. It is based on these factors:

1. Operating Margin
2. Trend of the Operating Margin (5-year average). The company with an uptrend profit margin has a higher rank.
••3. Consistency of the profitability
4. Piotroski F-Score
5. Predictability Rank•

The maximum rank is 10. A rank of 7 or higher means a higher profitability and may stay that way. A rank of 3 or lower indicates that the company has had trouble to make a profit.

Profitability Rank is not directly related to the Financial Strength Rank. But if a company is consistently profitable, its financial strength will be stronger.

Profitability & Growth : 7/10

vs
industry
vs
history
Operating margin (%) 11.89
PKI's Operating margin (%) is ranked higher than
79% of the 307 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 10.78 vs. PKI: 11.89 )
PKI' s 10-Year Operating margin (%) Range
Min: 1.62   Max: 10.86
Current: 11.89

1.62
10.86
Net-margin (%) 8.70
PKI's Net-margin (%) is ranked higher than
79% of the 307 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 7.12 vs. PKI: 8.70 )
PKI' s 10-Year Net-margin (%) Range
Min: -10.1   Max: 22.94
Current: 8.7

-10.1
22.94
ROE (%) 9.33
PKI's ROE (%) is ranked higher than
78% of the 302 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 8.58 vs. PKI: 9.33 )
PKI' s 10-Year ROE (%) Range
Min: -12.13   Max: 28.01
Current: 9.33

-12.13
28.01
ROA (%) 4.87
PKI's ROA (%) is ranked higher than
77% of the 310 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 4.35 vs. PKI: 4.87 )
PKI' s 10-Year ROA (%) Range
Min: -5.36   Max: 12.18
Current: 4.87

-5.36
12.18
ROC (Joel Greenblatt) (%) 54.92
PKI's ROC (Joel Greenblatt) (%) is ranked higher than
92% of the 307 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 19.02 vs. PKI: 54.92 )
PKI' s 10-Year ROC (Joel Greenblatt) (%) Range
Min: 3.69   Max: 78.05
Current: 54.92

3.69
78.05
Revenue Growth (%) 9.70
PKI's Revenue Growth (%) is ranked higher than
81% of the 280 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 6.20 vs. PKI: 9.70 )
PKI' s 10-Year Revenue Growth (%) Range
Min: -12.3   Max: 17.9
Current: 9.7

-12.3
17.9
EBITDA Growth (%) 8.30
PKI's EBITDA Growth (%) is ranked higher than
77% of the 235 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 7.70 vs. PKI: 8.30 )
PKI' s 10-Year EBITDA Growth (%) Range
Min: -20.9   Max: 35.2
Current: 8.3

-20.9
35.2
EPS Growth (%) 7.80
PKI's EPS Growth (%) is ranked higher than
75% of the 236 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 8.10 vs. PKI: 7.80 )
PKI' s 10-Year EPS Growth (%) Range
Min: -79   Max: 289.3
Current: 7.8

-79
289.3
» PKI's 10-Y Financials

Financials


Revenue & Net Income
Cash & Debt
Oprt. Cash Flow & Free Cash Flow

» Details

Guru Trades

Q3 2013

PKI Guru Trades in Q3 2013

PRIMECAP Management 1,553,900 sh (+23.16%)
Ken Fisher 656,810 sh (+2.84%)
Vanguard Health Care Fund 1,441,400 sh (unchged)
Columbia Wanger 972,000 sh (unchged)
Chuck Royce 3,592,620 sh (-10.42%)
Steven Cohen 42,321 sh (-79.8%)
Jim Simons 62,200 sh (-85.8%)
» More
Q4 2013

PKI Guru Trades in Q4 2013

Jim Simons 172,600 sh (+177.49%)
PRIMECAP Management 1,733,244 sh (+11.54%)
Vanguard Health Care Fund 1,441,400 sh (unchged)
Columbia Wanger 972,000 sh (unchged)
Steven Cohen Sold Out
Chuck Royce 3,577,620 sh (-0.42%)
Ken Fisher 616,535 sh (-6.13%)
» More
Q1 2014

PKI Guru Trades in Q1 2014

Steven Cohen 23,795 sh (New)
RS Investment Management 489,954 sh (New)
Jim Simons 322,000 sh (+86.56%)
PRIMECAP Management 2,116,074 sh (+22.09%)
Vanguard Health Care Fund 1,441,400 sh (unchged)
Columbia Wanger 972,000 sh (unchged)
Chuck Royce 3,540,320 sh (-1.04%)
Ken Fisher 609,140 sh (-1.2%)
» More
Q2 2014

PKI Guru Trades in Q2 2014

Joel Greenblatt 55,177 sh (New)
PRIMECAP Management 2,116,374 sh (+0.01%)
Vanguard Health Care Fund 1,441,400 sh (unchged)
Chuck Royce 3,540,320 sh (unchged)
Columbia Wanger 972,000 sh (unchged)
Ken Fisher 607,924 sh (-0.2%)
RS Investment Management 393,864 sh (-19.61%)
Jim Simons 170,800 sh (-46.96%)
» More
» Details

Insider Trades

Latest Guru Trades with PKI

(List those with share number changes of more than 20%, or impact to portfolio more than 0.1%)

GuruDate Trades Impact to Portfolio Price Range * (?) Current Price Change from Average Current Shares
Joel Greenblatt 2014-06-30 New Buy0.03%$41.97 - $47.52 $ 44.24-1%55177
PRIMECAP Management 2014-03-31 Add 22.09%0.02%$40.94 - $46.21 $ 44.241%2116074
PRIMECAP Management 2013-09-30 Add 23.16%0.01%$32.39 - $38.63 $ 44.2423%1553900
Vanguard Health Care Fund 2013-06-30 New Buy0.17%$30.35 - $34.95 $ 44.2435%1441400
Meridian Funds 2013-06-30 Add 20.08%0.15%$30.35 - $34.95 $ 44.2435%759500
Ray Dalio 2013-06-30 Sold Out 0.02%$30.35 - $34.95 $ 44.2435%0
David Dreman 2013-03-31 Sold Out 0.8%$31.74 - $35.86 $ 44.2429%0
Meridian Funds 2013-03-31 New Buy0.78%$31.74 - $35.86 $ 44.2429%632500
Ray Dalio 2013-03-31 New Buy0.02%$31.74 - $35.86 $ 44.2429%51497
PRIMECAP Management 2012-12-31 Add 28.06%0.01%$27.84 - $32.29 $ 44.2444%1208106
Mario Gabelli 2012-12-31 Sold Out 0.004%$27.84 - $32.29 $ 44.2444%0
PRIMECAP Management 2012-09-30 Add 56.14%0.02%$23.88 - $30.36 $ 44.2464%943359
Joel Greenblatt 2012-06-30 Sold Out 0.09%$24.96 - $27.9 $ 44.2467%0
Joel Greenblatt 2012-03-31 Reduce -41.22%0.06%$20.37 - $27.85 $ 44.2485%37369
PRIMECAP Management 2012-03-31 Add 241.19%0.01%$20.37 - $27.85 $ 44.2485%515906
David Dreman 2011-12-31 Add 251.88%0.49%$17.49 - $21.61 $ 44.24131%1525635
Ray Dalio 2011-12-31 Sold Out 0.06%$17.49 - $21.61 $ 44.24131%0
PRIMECAP Management 2011-12-31 Add 53.51%$17.49 - $21.61 $ 44.24131%151206
David Dreman 2011-09-30 New Buy0.21%$18.84 - $27.55 $ 44.2493%433571
Ray Dalio 2011-09-30 New Buy0.06%$18.84 - $27.55 $ 44.2493%212908
PRIMECAP Management 2011-09-30 New Buy$18.84 - $27.55 $ 44.2493%98500
Joel Greenblatt 2011-06-30 Add 442.85%0.27%$25.77 - $28.32 $ 44.2464%88507
Premium More recent guru trades are included for Premium Members only!!
» Interactive Charts

Peter Lynch Chart ( What is Peter Lynch Charts )

Ratios

vs
industry
vs
history
P/E(ttm) 26.20
PKI's P/E(ttm) is ranked higher than
83% of the 322 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 34.10 vs. PKI: 26.20 )
PKI' s 10-Year P/E(ttm) Range
Min: 5.27   Max: 3956.25
Current: 26.2

5.27
3956.25
P/B 2.40
PKI's P/B is ranked higher than
78% of the 322 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 3.17 vs. PKI: 2.40 )
PKI' s 10-Year P/B Range
Min: 0.88   Max: 2.66
Current: 2.4

0.88
2.66
P/S 2.30
PKI's P/S is ranked higher than
76% of the 322 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 3.03 vs. PKI: 2.30 )
PKI' s 10-Year P/S Range
Min: 0.72   Max: 2.49
Current: 2.3

0.72
2.49
PFCF 23.80
PKI's PFCF is ranked higher than
90% of the 322 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 127.16 vs. PKI: 23.80 )
PKI' s 10-Year PFCF Range
Min: 7.78   Max: 92.3
Current: 23.8

7.78
92.3
EV-to-EBIT 21.74
PKI's EV-to-EBIT is ranked higher than
78% of the 322 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 24.10 vs. PKI: 21.74 )
PKI' s 10-Year EV-to-EBIT Range
Min: 9.4   Max: 57.1
Current: 21.74

9.4
57.1
PEG 2.86
PKI's PEG is ranked higher than
85% of the 322 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 9999.00 vs. PKI: 2.86 )
PKI' s 10-Year PEG Range
Min: 1.86   Max: 46.41
Current: 2.86

1.86
46.41
Shiller P/E 32.60
PKI's Shiller P/E is ranked higher than
85% of the 322 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 9999.00 vs. PKI: 32.60 )
PKI' s 10-Year Shiller P/E Range
Min: 10.11   Max: 41.14
Current: 32.6

10.11
41.14
Current Ratio 1.87
PKI's Current Ratio is ranked higher than
63% of the 238 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 2.92 vs. PKI: 1.87 )
PKI' s 10-Year Current Ratio Range
Min: 0.74   Max: 2.13
Current: 1.87

0.74
2.13
Quick Ratio 1.39
PKI's Quick Ratio is ranked higher than
65% of the 238 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 1.84 vs. PKI: 1.39 )
PKI' s 10-Year Quick Ratio Range
Min: 0.54   Max: 1.7
Current: 1.39

0.54
1.7

Dividend & Buy Back

vs
industry
vs
history
Dividend Yield 0.60
PKI's Dividend Yield is ranked lower than
75% of the 176 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 1.35 vs. PKI: 0.60 )
PKI' s 10-Year Dividend Yield Range
Min: 0.58   Max: 2.43
Current: 0.6

0.58
2.43
Dividend Payout 0.16
PKI's Dividend Payout is ranked higher than
92% of the 322 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 9999.00 vs. PKI: 0.16 )
PKI' s 10-Year Dividend Payout Range
Min: 0.03   Max: 3.5
Current: 0.16

0.03
3.5
Yield on cost (5-Year) 0.60
PKI's Yield on cost (5-Year) is ranked lower than
71% of the 178 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 1.39 vs. PKI: 0.60 )
PKI' s 10-Year Yield on cost (5-Year) Range
Min: 0.58   Max: 2.43
Current: 0.6

0.58
2.43
Share Buyback Rate 1.30
PKI's Share Buyback Rate is ranked higher than
91% of the 238 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: -2.60 vs. PKI: 1.30 )
PKI' s 10-Year Share Buyback Rate Range
Min: 6.7   Max: -11.2
Current: 1.3

Valuation & Return

vs
industry
vs
history
Price/DCF (Projected) 1.62
PKI's Price/DCF (Projected) is ranked higher than
85% of the 322 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 4.31 vs. PKI: 1.62 )
PKI' s 10-Year Price/DCF (Projected) Range
Min: 0.52   Max: 114.71
Current: 1.62

0.52
114.71
Price/Median PS Value 1.32
PKI's Price/Median PS Value is ranked higher than
65% of the 322 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 1.15 vs. PKI: 1.32 )
PKI' s 10-Year Price/Median PS Value Range
Min: 0.22   Max: 1.96
Current: 1.32

0.22
1.96
Price/Peter Lynch Fair Value 1.92
PKI's Price/Peter Lynch Fair Value is ranked higher than
93% of the 322 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 9999.00 vs. PKI: 1.92 )
PKI' s 10-Year Price/Peter Lynch Fair Value Range
Min: 0.74   Max: 16.29
Current: 1.92

0.74
16.29
Earnings Yield (Greenblatt) 4.60
PKI's Earnings Yield (Greenblatt) is ranked higher than
69% of the 260 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 5.30 vs. PKI: 4.60 )
PKI' s 10-Year Earnings Yield (Greenblatt) Range
Min: 1.8   Max: 10.6
Current: 4.6

1.8
10.6
Forward Rate of Return (Yacktman) 15.67
PKI's Forward Rate of Return (Yacktman) is ranked higher than
78% of the 258 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 4.55 vs. PKI: 15.67 )
PKI' s 10-Year Forward Rate of Return (Yacktman) Range
Min: -4.4   Max: 17
Current: 15.67

-4.4
17

Business Description

Industry: Medical Instruments & Equipment » Medical Instruments & Supplies
Compare:WST, BAX, COV, TMO, COO » details
Traded in other countries:PKN.Germany
Perkinelmer Inc., a Massachusetts corporation was founded in 1947. The Company is a provider of technology, services and solutions to the diagnostics, research, environmental, industrial and laboratory services markets. Through its advanced technologies, solutions, and services, it addresses critical issues that help to improve the health and safety of people and their environment. The Company reports its business in two segments: Human Health and Environmental Health. Human Health segment concentrates on developing diagnostics, tools and applications to help detect diseases earlier and more accurately and to accelerate the discovery and development of critical new therapies. Within the Human Health segment, it serves both the diagnostics and research markets. It provides early detection for genetic disorders from pre-conception to early childhood, as well as digital x-ray flat panel detectors and infectious disease testing for the diagnostics market. In the research market, it provides a broad suite of solutions including reagents, liquid handling and detection technologies that enable researchers to improve the drug discovery process. Human Health segment offers additional products under various brand names, including AlphaLISA, AlphaScreen, AutoDELFIA, Columbus, EnSpire, EnVision, Evolution, FMT, Genoglyphix, Geospizer, inForm, IVIS, JANUS, LabChip, LANCE, LifeCycle, Living Image, Maestro, MultiPROBE, NEN, NTD Labs, Nuance, Oncoglyphix, Opera, Operetta, Packard, Pannoramic, Quantum, ScanArray, Sciclone, SignatureChip, Signature Precision Panel, Specimen Gate, SureFire, TRIO, Twister, VariSpec, Vectra, ViaCord, VICTOR, Volocity, Wizard, XRD amorphous silicon FPDs, and Zephyr. Environmental Health segment provides technologies and applications to facilitate the creation of safer food and consumer products, more secure surroundings and efficient energy resources. Environmental Health segment serves the environmental, industrial and laboratory services markets. For the environmental market, it provides analytical technologies that address the quality of its environment, sustainable energy development, and help ensure safer food and consumer products. Its technologies are used to detect and help reduce the impact products and industrial processes may have on its environment. It provides a variety of solutions that detect the presence of potentially dangerous materials, including lead and phthalates, in toys and other consumer products to help ensure their safety for use or consumption. It provides analytical instrumentation for the industrial market which includes the semiconductor, chemical, petrochemical, lubricant, construction, office equipment and quality assurance industries. All of the Company's businesses market their products and services directly through their own specialized sales forces. The Company's operations are subject to various foreign, federal, state and local environmental and safety laws and regulations.
» More Articles for PKI

Headlines

Articles On GuruFocus.com
Vanguard Health Care Fund Gains 27%, Buys 4 New Stocks Jul 31 2013 
The Best Dividends on April 18, 2012 Apr 18 2012 
PerkinElmer Inc. Reports Operating Results (10-K) Mar 01 2011 
PerkinElmer Inc. Reports Operating Results (10-Q) Nov 10 2010 
PerkinElmer Inc. Reports Operating Results (10-Q) Aug 10 2010 
PerkinElmer Inc. Reports Operating Results (10-Q) May 13 2010 
PerkinElmer Inc. (PKI) Chairman, President & CEO Robert F Friel sells 150,000 Shares Dec 17 2009 
PerkinElmer Acquires Leading Diagnostics Company in China Sep 08 2009 
PerkinElmer Inc. Reports Operating Results (10-Q) Aug 14 2009 
PerkinElmer Announces Financial Results for the Second Quarter of 2009 Jul 30 2009 

More From Other Websites
PERKINELMER INC Files SEC form 8-K, Change in Directors or Principal Officers Sep 12 2014
Louis Culot Appointed as BioData's CEO Sep 02 2014
PERKINELMER INC Financials Aug 12 2014
Coverage initiated on PerkinElmer by Stifel Aug 12 2014
PERKINELMER INC Files SEC form 10-Q, Quarterly Report Aug 05 2014
Dr. Phillip P. Chan, the CEO and President of CytoSorbents Corporation (CTSO), Interviews with The... Aug 01 2014
PerkinElmer Q2 Earnings Meet but Revenues Miss Estimates Aug 01 2014
PerkinElmer profit meets Wall Street view; not seeking inversion Jul 31 2014
PerkinElmer Inc Earnings Call scheduled for 5:00 pm ET today Jul 31 2014
PERKINELMER INC Files SEC form 8-K, Results of Operations and Financial Condition, Financial... Jul 31 2014
PerkinElmer 2nd quarter profit meets Wall Street view Jul 31 2014
PerkinElmer Announces Financial Results for the Second Quarter of 2014 Jul 31 2014
Q2 2014 PerkinElmer Earnings Release - After Market Close Jul 31 2014
PerkinElmer Board Declares Quarterly Dividend Jul 24 2014
Danaher Q2 Earnings, Guidance Disappoint Wall Street Jul 17 2014
PerkinElmer to Hold Earnings Call on Thursday, July 31, 2014 Jul 07 2014
PerkinElmer: 6 Different Insiders Have Sold Shares This Month Jun 22 2014
PerkinElmer Launches New Air Monitoring Service Jun 10 2014
A Few Medical Research Stocks Break Out, Others Basing Jun 09 2014
PerkinElmer Launches Novel Real-Time Air Quality Sensor Network Jun 09 2014

Personalized Checklist








Within your circle of competence?
Macro economic environment favorable?
High quality business?
Enough margin of safety with stocks?
Gurus are buying?
Insiders are buying?
Management capable and shareholder friendly?
Catalyst for stock price to appreciate?
Your level of confidence with the research?

Get WordPress Plugins for easy affiliate links on Stock Tickers and Guru Names | Earn affiliate commissions by embedding GuruFocus Charts
GuruFocus Affiliate Program: Earn up to $400 per referral. ( Learn More)
Free 7-day Trial
FEEDBACK